Baxalta
North America, Illinois, United States, Illinois City
Description
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Investor Profile
Baxalta has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Genetics.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Genetics
- Medical
- Biopharma
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
